Get the Daily Brief
Latest Biotech News
Regulatory and IPO momentum in immunology and oncology
Two high-profile market moves highlighted biotech’s renewed appetite for immunology and oncology franchises. TRex Bio priced a $117 million IPO to advance Treg-activating candidates, including...
FDA approval advances immune checkpoint therapy in dMMR colon cancer
FDA approved atezolizumab with chemotherapy for adjuvant treatment of stage III dMMR colon cancer following results from the phase III ATOMIC trial. The study reported a 50% reduction in the risk...
Clinical evidence update: perioperative use of GLP-1 drugs before thyroid surgery
A large target trial emulation evaluated whether patients with type 2 diabetes should stop or continue GLP-1 receptor agonists before thyroidectomy. Continuing therapy was not associated with...
First-in-human testing for noninvasive neuromodulation in cancer wasting
OnVagus received approval to begin the first human trial of its noninvasive vagus nerve-stimulation device for cancer-related wasting at MD Anderson Cancer Center. The study marks an early...
Cancer immunology mechanisms: malignant ascites immune profiling and therapy-enabling biology
A Mass General Brigham-led study in Science Immunology used multiomic analysis of malignant ascites to identify a rare immune cell population that may help metastatic tumors evade immunity. The...
Digital health and AI in care delivery: reducing inequity and improving clinical documentation
Two digital health studies pointed to different, practical pathways for improving outcomes and quality. A randomized trial in Germany found that pre-visit computer-assisted history-taking plus...
AI-enabled diagnostics: heart and cancer imaging without major workflow disruption
New imaging and signal-processing studies showcased AI progress toward opportunistic screening and earlier detection. One study reported that AI software can extract reliable bone mineral density...
Infectious disease care: evidence on resistance and treatment gaps
Multiple infectious disease updates underscored persistent diagnostic and treatment friction. A pilot study in Brazil reported that the Enhanced Liver Fibrosis blood test rises with periportal...
Translational immunotherapy engineering: moving beyond conventional targets in oncology
Engineering approaches aimed at reshaping immune responses featured prominently. A new study designed a CLDN18.2-targeting T-cell engager using RFdiffusion, showing that dendritic-cell...
Open science pipeline: new computation for mutation detection in regulatory DNA
A new computational pipeline, HiFIseek, aims to identify hidden cancer-driving mutations in the genome’s non-coding regulatory regions. The tool systematically links damaging variants to cancer...
Regulatory/clinical update in oncology and immunotherapy
FDA has approved atezolizumab with chemotherapy for adjuvant treatment of stage III dMMR colon cancer following the phase 3 ATOMIC trial, delivering a 50% reduction in the risk of recurrence or...
IPO momentum for immune-modulating cell therapy and inflammation targets
TRex Bio priced a $117 million IPO to advance drugs aimed at rebalancing immune responses, while Retension Pharmaceuticals raised $45 million in a separate Nasdaq debut tied to hypertension...
Clinical trial signal in head and neck cancer via chemo-immunotherapy de-escalation
A phase 2 trial reported that preoperative chemo-immunotherapy with sintilimab in locally advanced head and neck cancer achieved major pathological responses in 59.1% of patients. Responders then...
New drug performance signal in rare hematology via complement inhibition in pregnancy
A global pharmacovigilance analysis of 354 pregnancies reported no new safety signals for ravulizumab, a complement inhibitor, aligning outcomes with the established profile of eculizumab. The...
AI-enabled diagnostic tools moving toward screening workflows
A study using routine breast ultrasound images trained a deep learning radiomics model to predict sentinel lymph node metastasis preoperatively. Results showed moderate discrimination across...
Precision immunology and cancer biology: resistance and tumor-immune interactions
Researchers reported a shared vulnerability across shifting triple-negative breast cancer phenotypic states: DNA damage tolerance enzymes including POLζ and CHK1. Blocking these targets, alone or...
New targeted microbiology and antimicrobial adjunct concept
An experimental pipeline combined an antimicrobial strategy with a fast mucosal delivery concept: a dissolvable film engineered to deliver the PFOR-inhibiting antimicrobial amixicile into...
AI and healthcare operations: systematic performance on nursing workloads and care delivery
A randomized controlled trial in Japan tested home-visit nurses using a guideline-informed AI chatbot during simulated heart failure cases. Nurses reported lower mental effort and task difficulty,...
Clinical evidence for GLP-1 use around surgery in diabetes patients
A large target trial emulation compared continuing versus stopping GLP-1 receptor agonists before thyroidectomy in adults with type 2 diabetes. Continuing GLP-1s was not associated with excess...
Public health and infectious disease: malaria control signal and surveillance methods
A pooled analysis of three countries’ phase 3 trials in Kenya, Mali, and Zambia found that targeted sugar baits did not significantly reduce clinical malaria, with a possible dose-response signal...